J. Laven

Reproductive Medicine · 2002–2018

A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Reproductive Medicine — 59 citations into it; #158 of 208 by trust here, #16 by citations

Whom J. Laven trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Bart C. J. M. Fauser

Who trusts J. Laven overall

1. Bart C. J. M. Fauser
2. S. Broer
3. Frank J. Broekmans

Papers from J. Laven's perspective

Ordered by how strongly the researchers J. Laven trusts endorse each paper. Same corpus, a different order for every researcher.

1. Anti-Müllerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary. (Endocrinology)
2. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. (Human Reproduction)
3. AGREE II: advancing guideline development, reporting and evaluation in health care (Canadian Medical Association Journal)
4. Polycystic ovary syndrome (Nature Reviews Disease Primers)
5. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. (European Journal of Endocrinology)
6. Regulation of ovarian function: the role of anti-Müllerian hormone. (Reproduction)
7. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. (Human Reproduction)
8. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline (Journal of Clinical Endocrinology and Metabolism)
9. Ovarian aging: mechanisms and clinical consequences. (Endocrine reviews)
10. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. (Molecular human reproduction)

Their papers

• Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (2018) — 2,461 citations
• Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis. (2016) — 721 citations
• Polycystic ovary syndrome (2016) — 4,774 citations
• Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. (2015) — 884 citations
• Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. (2014) — 608 citations
• Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. (2012) — 1,611 citations
• Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. (2004) — 1,325 citations
• Ultrasound assessment of the polycystic ovary: international consensus definitions. (2003) — 1,033 citations
• Antimüllerian hormone serum levels: a putative marker for ovarian aging. (2002) — 933 citations